Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Sleep Apnea

How IBD Stock Of The Day Inspire Medical Systems Won A Breakout

Inspire is Wednesday's IBD Stock Of The Day. The sleep apnea expert reported massive sales growth, leading shares to break out.

Investors Business Daily

ResMed rings up record $1B in sales in latest quarter led by connected sleep apnea devices

For the past 18 months, ResMed Chief Executive Mick Farrell has been publicly outspoken in urging that medical devices get priority access to semiconductors amid global chip shortages coming out of the pandemic.

Tribune News Service

Will your smartphone be the next doctor’s office?

The same devices used to take selfies and type out tweets are being repurposed and commercialized for quick access to information needed for monitoring a patient’s health. A fingertip pressed against a phone’s camera lens can measure a heart rate. The microphone, kept by the bedside, can screen for sleep…

Tribune News Service

From analysis to the latest developments in health,
read the most diverse news in one place.

Sleep apnea device recall drags on, stoking anger from users

A massive recall of sleep apnea machines is expected to drag into next year

The Independent UK

This easy, no-cost solution could help treat a super common sleep condition

Sleep apnea is a highly common condition, but its diagnostic criteria lack strong evidence and doctors often recommend expensive treatments. This writer has a free treatment suggestion.

Inverse

Severe sleep apnea diagnosis panics reporter until he finds a simple, no-cost solution

I woke up in a strange bedroom with 24 electrodes glued all over my body and a plastic mask attached to a hose covering my face.

Tribune News Service

If you're a problem snorer you can get £156 a week from DWP

More than 1,300 people across the UK are being supported through PIP for sleep apnea

Wales Online

Read news from The Economist, FT, and more,
with one subscription

Snorers can get up to £156 a week in DWP benefits - and thousands do already

Snoring can be a sign of a more serious medical condition like sleep apnea, which can qualify you for Personal Independence Payment benefits of up to £156 every week

Daily Mirror

Claim PIP for sleep apnea and DWP could give you up to £156 each week to help with costs

More than 1,300 people across the UK are being supported through PIP for sleep apnea.

Daily Record

Bumrungrad rests easy with sleep clinic

Bumrungrad International Hospital has announced the opening of its Comprehensive Sleep Clinic to address sleep-related conditions.

Bangkok Post

What SVB Says On Axsome's Strategy Review On Sunosi For Sleeping Disorder

Axsome Therapeutics Inc (NASDAQ: AXSM) held an investor event to review its strategy with Sunosi, which is indicated for excessive daytime sleepiness (EDS) in narcolepsy and obstructive sleep apnea (OSA). SVB Leerink says its view on Sunosi has not changed.

Benzinga

ResMed Strengthens Its Out-Of-Hospital Software Solutions Position With Latest Acquisition - Read How

ResMed Inc (NYSE:RMD) has agreed to acquire privately-held MEDIFOX DAN, a Germany-based provider of out-of-hospital software solutions, from Hg, a software and services investor. MEDIFOX DAN's clinical, financial, and operational solutions are similar to ResMed's U.S. SaaS brands, MatrixCare and Brightree. MEDIFOX DAN's German customer base is complementary to the customers of ResMed's U.S.-based…

Benzinga

Kansas man says he got lung cancer from CPAP sleep apnea machine. He’s suing

KANSAS CITY, Mo. — A Johnson County, Kansas, man blames his sleep apnea machine for giving him lung cancer and is suing the manufacturer, which last year recalled the machine and several other breathing-aid devices.

Tribune News Service

Incannex Reveals Clinical Trial Results On Dronabinol-Based Drug For Obstructive Sleep Apnea

Incannex Healthcare Limited (NASDAQ: IXHL) (ASX:IHL), a clinical-stage pharmaceutical company developing medicinal cannabinoid pharmaceutical products and psychedelic medicine therapies for unmet medical needs, has completed an analysis of data from the Phase 2 proof-of-concept clinical trial invest

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

1 … 3 4 5 6

Organisations

Social Security Scotland

University of Washington

From analysis to the latest developments in health,
read the most diverse news in one place.

Topics

Read news from The Economist, FT, and more,
with one subscription

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.